Genmab | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
Agios Pharmaceuticals USD 45.87M 4.34M 2025-06
Almirall EUR 91.3M 55.52M 2025-03
Amarin USD 36.57M 397K 2025-03
Amgen USD 1.69B 4M 2025-06
argenx SE USD 321.35M 45.11M 2025-06
AstraZeneca USD 5.01B 1.42B 2025-06
Bayer EUR 3.55B 162M 2025-06
BioMarin Pharmaceutical USD 232.28M 26.16M 2025-06
Demant DKK 5.63B 2.77B 2024-12
Exelixis USD 134.86M 2.32M 2025-07
Fresenius Medical Care EUR 792M 41M 2025-06
Galapagos EUR 30.67M 13.12M 2025-06
Genmab DKK 144M 18M 2025-06
GlaxoSmithKline GBP 2.14B 80M 2025-06
GN Store Nord DKK 1.52B 99M 2025-03
GRIFOLS EUR 282.76M 41.9M 2025-06
Hikma Pharmaceutical USD 288M 8M 2024-12
Insmed USD 76.44M 71.11M 2025-06
Merck EUR 1.48B 9M 2025-06
Novartis USD 3.44B 384M 2025-06
Regeneron Pharmaceuticals USD 634.2M 1.2M 2025-06
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.63B 408M 2025-06
UCB EUR 1.29B 221M 2024-12


Genmab Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Aug 2025.